Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
Add more filters










Publication year range
1.
Sci Rep ; 10(1): 14415, 2020 09 15.
Article in English | MEDLINE | ID: mdl-32934273

ABSTRACT

The Antarctic continental margin supplies the densest bottom water to the global abyss. From the late twentieth century, an acceleration in the long-term freshening of Antarctic Bottom Waters (AABW) has been detected in the Australian-Antarctic Basin. Our latest hydrographic observations reveal that, in the late 2010s, the freshening trend has reversed broadly over the continental slope. Near-bottom salinities in 2018-2019 were higher than during 2011-2015. Along 170° E, the salinity increase between 2011 and 2018 was greater than that observed in the west. The layer thickness of the densest AABW increased during the 2010s, suggesting that the Ross Sea Bottom Water intensification was a major source of the salinity increase. Freshwater content on the continental slope decreased at a rate of 58 ± 37 Gt/a in the near-bottom layer. The decadal change is very likely due to changes in Ross Sea shelf water attributable to a decrease in meltwater from West Antarctic ice shelves for the corresponding period.

2.
Acta Virol ; 58(4): 359-63, 2014.
Article in English | MEDLINE | ID: mdl-25518718

ABSTRACT

The Middle East syndrome coronavirus (MERS-CoV) is a recently emerging betacoronavirus with high fatality. Recently, dipeptidyle peptidase (CD26, DPP4) was identified as the host cell receptor for MERS-CoV. Interestingly, despite of common presence of DPP4 receptors the binding and infection of various cells shows imminent variability. In this report, we provide a tool for prediction of the host tropism of the virus based on the host receptor binding interface. We found out that, in the binding of MERS-CoV to cells the amino acid residues in lancets 4 and 5 of DPP4 receptor, namely K267, Q286, T288, R317, R336, Q344 A291, L294, and I295 are involved. Changes in these residues correspond to profound decrease in virus binding to cells. The nine residues at the interface between the virus spikes and the lancets 4 and 5 of host DPP4 can be used as a predictive tool for the host tropism and virus affinity to host cell receptors.


Subject(s)
Coronavirus Infections/enzymology , Coronavirus Infections/veterinary , Dipeptidyl Peptidase 4/chemistry , Middle East Respiratory Syndrome Coronavirus/physiology , Receptors, Virus/chemistry , Viral Tropism , Amino Acid Sequence , Animals , Coronavirus Infections/genetics , Coronavirus Infections/virology , Dipeptidyl Peptidase 4/genetics , Dipeptidyl Peptidase 4/metabolism , Humans , Mammals/genetics , Mammals/virology , Middle East Respiratory Syndrome Coronavirus/classification , Middle East Respiratory Syndrome Coronavirus/genetics , Molecular Sequence Data , Receptors, Virus/genetics , Receptors, Virus/metabolism , Sequence Alignment
3.
Drugs Today (Barc) ; 49(5): 325-39, 2013 May.
Article in English | MEDLINE | ID: mdl-23724412

ABSTRACT

Corticosteroids (CST) are the gold standard for asthma management and for several decades have been considered the cornerstone for asthma control. With the recent advent of genomic and structural analysis technologies, the molecular basis of the side effects, toxicity and resistance mechanisms of drug treatment are better understood. With respect to CST, there is consistent evidence that while CST therapy improves asthma symptoms, it does not alter the natural course of asthma or offer clear long-lasting improvement of respiratory performance. Therefore, the development of drugs capable of minimizing or avoiding CST side effects, toxicity and resistance could be the way forward for establishing new asthma therapies. This review summarizes the molecular basis of corticosteroid mechanisms of action and the related mechanisms influencing side effects and resistance. The future of CST adjunctive or replacement therapy is also briefly discussed.


Subject(s)
Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Glucocorticoids/therapeutic use , Animals , Anti-Asthmatic Agents/adverse effects , Anti-Asthmatic Agents/pharmacology , Asthma/physiopathology , Drug Design , Drug Resistance , Glucocorticoids/adverse effects , Glucocorticoids/pharmacology , Humans , Molecular Targeted Therapy
4.
Indian J Pharm Sci ; 74(6): 592-6, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23798790

ABSTRACT

Ivermectin, chloramphenicol, ampicillin and tetracycline HCl are common drugs in human and veterinary practice. The purpose of this study is to investigate the possible binding interactions between ivermectin and the antibiotics chloramphenicol, ampicillin and tetracycline HCl. Isothermal titration calorimetry was used to determine the binding interactions between ivermectin and these antibiotics. Results indicated that, about three molecules of ampicillin can bind to one molecule of ivermectin and about one molecule of chloramphenicol with one molecule of ivermectin. However, no binding stoichiometry can be detected with tetracycline HCl-ivermectin titration. Furthermore, the binding interactions were accompanied by various biophysical and biochemical mechanisms. This is the first report of such interactions of ivermectin with chloramphenicol, ampicillin and tetracycline HCl. There are possible binding interactions of ivermectin with chloramphenicol and ampicillin. Further studies are required for detecting the impact of this binding on biological aspects of drug actions.

5.
Cancer Gene Ther ; 17(6): 398-408, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20094072

ABSTRACT

We examined the expression levels of microRNAs (miRNAs (miRs)) in colorectal tumors (63 cancer specimens and 65 adenoma specimens) and paired non-tumorous tissues. Decreased expression of miR-143 and -145 was frequently observed in the adenomas and cancers tested, compared with miR-34a downregulation and miR-21 upregulation. Expression profiles of miR-143 and -145 were not associated with any clinical features. As the downregulation of miR-143 and -145 was observed even in the early phase of adenoma formation, the decreased expression of both miRs would appear to contribute mainly to the initiation step of tumorigenesis, not to the progression stage, and not to clinical prognostic factors. For clinical application, we changed the sequences of the passenger strand in the miR-143 duplex and performed chemical modification at the 3'-overhang portion of miR-143, leading to greater activity and stability to nuclease. The cell growth inhibitory effect of the chemically modified synthetic miR-143 in vitro was greater than that of endogenous miR-143. The miR-143 showed a significant tumor-suppressive effect on xenografted tumors of DLD-1 human colorectal cancer cells. These findings suggest that miR-143 and -145 are important onco-related genes for the initiation step of colorectal tumor development and that the chemically modified synthetic miR-143 may be a hopeful candidate as an RNA medicine for the treatment of colorectal tumors.


Subject(s)
Colonic Neoplasms/genetics , Colorectal Neoplasms/genetics , MicroRNAs/genetics , Adenoma/genetics , Adenoma/pathology , Adenoma/prevention & control , Adult , Aged , Aged, 80 and over , Animals , Cell Line, Tumor , Cell Proliferation/drug effects , Colonic Neoplasms/pathology , Colonic Neoplasms/prevention & control , Colorectal Neoplasms/pathology , Colorectal Neoplasms/prevention & control , Female , Gene Expression Regulation, Neoplastic , Humans , Injections, Intravenous , Male , Mice , Mice, Nude , MicroRNAs/administration & dosage , MicroRNAs/chemical synthesis , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Transfection , Tumor Burden/drug effects , Tumor Burden/genetics , Xenograft Model Antitumor Assays , Young Adult
6.
Parasitology ; 136(1): 11-25, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19126267

ABSTRACT

Plasmodium falciparum thymidylate kinase (PfTMK) can tolerate a range of substrates, which distinguishes it from other thymidylate kinases. The enzyme not only phosphorylates TMP and dUMP but can also tolerate bulkier purines, namely, dGMP, GMP, and dIMP. In order to probe the flexibility of PfTMK in accommodating ligands of various sizes, we developed 6 mutant enzymes and subjected these to thermodynamic, inhibitory and catalytic evaluation. Kinase activity was markedly affected by introducing a larger lysine residue instead of A111. The lack of the hydroxyl group after inducing mutation of Y107F affected enzyme activity, and had a more severe impact on dGMP kinase activity. PfTMK can be inhibited by both purine and pyrimidine nucleosides, raising the possibility of developing highly selective drugs. Thermodynamic analysis revealed that enthalpic forces govern both purine and pyrimidine nucleoside monophosphate binding, and the binding affinity of both substrates was highly comparable. The heat produced due to dGMP binding is lower than that attributable to TMP. This indicates that additional interactions occur with TMP, which may be lost with larger dGMP. Targeting PfTMK not only affects thymidine nucleotide synthesis but may also affect purine nucleotides, and thus the enzyme represents an attractive antimicrobial target.


Subject(s)
Drug Discovery , Nucleoside-Phosphate Kinase , Plasmodium falciparum/enzymology , Animals , Calorimetry , Enzyme Activation/drug effects , Kinetics , Models, Molecular , Mutagenesis, Site-Directed , Nucleoside-Phosphate Kinase/antagonists & inhibitors , Nucleoside-Phosphate Kinase/chemistry , Nucleoside-Phosphate Kinase/genetics , Nucleoside-Phosphate Kinase/metabolism , Nucleosides/chemistry , Nucleosides/pharmacology , Protein Binding/physiology , Protein Structure, Tertiary , Thermodynamics
7.
Br J Cancer ; 93(4): 441-9, 2005 Aug 22.
Article in English | MEDLINE | ID: mdl-16106250

ABSTRACT

We previously demonstrated a characteristically high sensitivity of pancreatic cancer cells to interferon alpha (IFN-alpha) gene transfer, which induced a more prominent growth suppression and cell death in pancreatic cancer cells than in other types of cancers and normal cells. The IFN-alpha protein can exhibit both direct cytotoxicity and indirect immunological antitumour activity. Here, we dissected and examined the two mechanisms, taking advantage of the fact that IFN-alpha did not show any cross-species activity in its in vivo effect. When a human IFN-alpha adenovirus was injected into subcutaneous xenografts of human pancreatic cancer cells in nude mice, tumour growth was significantly suppressed due to cell death in an adenoviral dose-dependent manner. The IFN-alpha protein concentration was markedly increased in the injected subcutaneous tumour, but leakage of the potent cytokine into the systemic blood circulation was minimal. When a mouse IFN-alpha adenovirus was injected into the same subcutaneous tumour system, all mice showed significant tumour inhibition, an effect that was dependent on the indirect antitumour activities of IFN-alpha, notably a stimulation of natural killer cells. Moreover, in this case, tumour regression was observed not only for the injected subcutaneous tumours but also for the untreated tumours at distant sites. This study suggested that a local IFN-alpha gene therapy is a promising therapeutic strategy for pancreatic cancer, due to its dual mechanisms of antitumour activities and lack of significant toxicity.


Subject(s)
Genetic Therapy , Interferon-alpha/genetics , Pancreatic Neoplasms/therapy , Adenoviridae/genetics , Animals , Cell Line, Tumor , Cell Proliferation , Female , Gene Transfer Techniques , Genetic Vectors , Humans , Interferon-alpha/biosynthesis , Interferon-alpha/therapeutic use , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Metastasis/immunology , Neoplasm Transplantation , Pancreatic Neoplasms/immunology , Pancreatic Neoplasms/pathology , Transplantation, Heterologous
8.
Nutr Cancer ; 39(1): 96-101, 2001.
Article in English | MEDLINE | ID: mdl-11588908

ABSTRACT

The Long-Evans Cinnamon (LEC) rat is a well-characterized model of spontaneous hepatocarcinogenesis. It has been shown that dietary administration of lycopene or the herbal medicine Sho-saiko-to (TJ-9) has anticarcinogenic activity, although the mechanism by which these products protect against carcinogenesis is not well known. We investigated the outcome of administration of lycopene and TJ-9 on the occurrence of hepatic neoplasia in LEC rats. A diet containing 0.005% lycopene (originally the product of tomato oleoresin containing 13% lycopene) and 1% TJ-9 (crude extracts of 7 herbs: bupleurum root, pinellia tuber, scutellaria root, jujube fruit, ginseng root, glycyrrhiza root, and ginger rhizome) was administered from 6 weeks of age until the rats were sacrificed at 76 weeks of age, at which time most of the nontreated animals were known to have hepatocellular carcinoma (HCC). Development of HCC in treated groups was analyzed histologically by comparison with untreated controls. Glutathione S-transferase placental form (GST-P) was analyzed by an immunohistochemical method. Concentration of copper, iron, and zinc, which appear to play a role in hepatocarcinogenesis in LEC rats, was analyzed. The percent areas of HCC in the liver specimens of control, lycopene, and TJ-9 groups were 17.9 +/- 17.1%, 27.2 +/- 20.8%, and 27.6 +/- 18.4%, respectively. These intergroup differences were not significant. The percent area, number of areas, and mean size of area staining positively for GST-P revealed no significant differences between the groups. The number of GST-P-positive areas within the HCC lesions was greater in the TJ-9 group than in the control or lycopene group (p = 0.024 and p = 0.012, respectively). The study also demonstrated a lower concentration of iron in livers of the lycopene group than the control group (p = 0.019). There were no differences in serum alpha-fetoprotein levels or the cumulative survival rates between the groups. In conclusion, long-term administration of lycopene or TJ-9 did not reduce the risk of hepatocarcinogenesis in LEC rats.


Subject(s)
Anticarcinogenic Agents/administration & dosage , Carcinoma, Hepatocellular/prevention & control , Carotenoids/administration & dosage , Drugs, Chinese Herbal/administration & dosage , Liver Neoplasms/prevention & control , Animals , Carcinoma, Hepatocellular/epidemiology , Copper/analysis , Disease Models, Animal , Glutathione Transferase/metabolism , Immunohistochemistry , Incidence , Iron/analysis , Liver/chemistry , Liver/enzymology , Liver/pathology , Liver Neoplasms/epidemiology , Lycopene , Male , Rats , Rats, Inbred LEC , Survival Rate , Zinc/analysis
9.
J Biol Chem ; 276(49): 46394-9, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-11583992

ABSTRACT

An FMN-dependent NADH-azoreductase of Escherichia coli was purified and analyzed for identification of the gene responsible for azo reduction by microorganisms. The N-terminal sequence of the azoreductase conformed to that of the acpD gene product, acyl carrier protein phosphodiesterase. Overexpression of the acpD gene provided the E. coli with a large amount of the 23-kDa protein and more than 800 times higher azoreductase activity. The purified gene product exhibited activity corresponding to that of the native azoreductase. The reaction followed a ping-pong mechanism requiring 2 mol of NADH to reduce 1 mol of methyl red (4'-dimethylaminoazobenzene-2-carboxylic acid) into 2-aminobenzoic acid and N,N'-dimethyl-p-phenylenediamine. On the other hand, the gene product could not convert holo-acyl carrier protein into the apo form under either in vitro or in vivo conditions. These data indicate that the acpD gene product is not acyl carrier protein phosphodiesterase but an azoreductase.


Subject(s)
NADH, NADPH Oxidoreductases/genetics , Phosphoric Diester Hydrolases/genetics , Amino Acid Sequence , Base Sequence , Chromatography, Liquid/methods , DNA Primers , Electrophoresis, Polyacrylamide Gel , Kinetics , Molecular Sequence Data , NADH, NADPH Oxidoreductases/chemistry , NADH, NADPH Oxidoreductases/isolation & purification , NADH, NADPH Oxidoreductases/metabolism , Nitroreductases , Phosphoric Diester Hydrolases/chemistry , Phosphoric Diester Hydrolases/isolation & purification , Phosphoric Diester Hydrolases/metabolism , Sequence Homology, Amino Acid , Spectrum Analysis
10.
J Biochem ; 129(1): 101-5, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11134963

ABSTRACT

Recombinant S-adenosyl-L-homocysteine (SAH) hydrolase of the malaria parasite Plasmodium falciparum was expressed in Escherichia coli, purified to homogeneity and characterized. Comparison of the malaria parasite SAH hydrolase with that derived from the human gene indicated marked differences in kcat values. The values of both forward and reverse reactions of P. falciparum SAH hydrolase are more than 21-fold smaller than those of the human enzyme. Km values of the parasite and human SAH enzymes are 1.2 and 7.8 microM, respectively. On the other hand, IC50 values of neplanocin A, a strong inhibitor of SAH hydrolase and a growth inhibitor of P. falciparum, are 101 nM for the parasite enzyme and 47 nM for human enzyme. P. falciparum SAH hydrolase has been thought to be a target for a chemotherapeutic agent against malaria. This study may make it possible to develop a specific inhibitor for the parasite SAH hydrolase.


Subject(s)
Adenosine/pharmacology , Enzyme Inhibitors/pharmacology , Hydrolases/isolation & purification , Plasmodium falciparum/enzymology , Adenosine/analogs & derivatives , Adenosylhomocysteinase , Animals , Escherichia coli/genetics , Hydrogen-Ion Concentration , Hydrolases/antagonists & inhibitors , Hydrolases/chemistry , Hydrolases/genetics , Kinetics , Molecular Weight , Plasmodium falciparum/genetics , Reaction Time , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Temperature
11.
Nucleic Acids Res Suppl ; (1): 233-4, 2001.
Article in English | MEDLINE | ID: mdl-12836350

ABSTRACT

The antitumor ribonucleoside analogue 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), synthesized in 1995, has strong antitumor activity. In mouse mammary tumor FM3A cells, ECyd was rapidly phosphorylated to ECyd-triphosphate (ECTP) as the final product, strongly inhibiting RNA synthesis. The ultimate metabolite of ECyd, ECTP, is stable in cultured FM3A cells with a half-life of 21 hr; ECyd is on a "closed" metabolic pathway to ECTP. Deaminated ECyd derivatives were minor metabolites in the cells treated with Ecyd; therefore cytidine forms probably were not converted to uridine forms at the nucleoside or nucleotide stage. The characteristics of ECyd may be important for the antitumor activity. RNA polymerase in the nucleus was inhibited competitively by ECTP; the ki value was 21 nM. ECyd induced DNA and 28S ribosomal RNA fragnetations. The cleavage pattern of rRNA resembled in that mediated by RNase L. The results suggested that RNase L related mechanisms might be involved in the antitumor activity of ECyd.


Subject(s)
Antineoplastic Agents/pharmacology , Cytidine/analogs & derivatives , Cytidine/pharmacology , Animals , Antineoplastic Agents/chemistry , Apoptosis , Cytidine/chemistry , Endoribonucleases/metabolism , Mice , Models, Biological , RNA/biosynthesis , RNA, Ribosomal/metabolism , Tumor Cells, Cultured
12.
Nucleic Acids Res Suppl ; (1): 11-2, 2001.
Article in English | MEDLINE | ID: mdl-12836239

ABSTRACT

3'-3'-Linked oligodeoxynucleotides (ODNs) with the anthraquinonyl group at the junction point were synthesized on a DNA synthesizer using a controlled pore glass (CPG), which has pentaerythritol carrying the intercalator at one of the four hydroxymethyl groups. Stability of the triplexes with the target duplexes was studied by thermal denaturation. The 3'-3'-linked ODNs with the anthraquinonyl group enhanced the thermal stability of the triplexes when compared with those without the intercalator and the unmodified nonamer. The inhibitory activity of the 3'-3'-linked ODNs against the cleavage of the target DNA by the restriction enzyme Hind III was tested. It was found that the 3'-3'-linked ODN with the anthraquinonyl group at the junction point inhibited the cleavage by the enzyme more effectively than the nonamer and the 3'-3'-linked ODN without the intercalator.


Subject(s)
Anthraquinones/chemistry , DNA/chemical synthesis , Intercalating Agents/chemistry , Oligodeoxyribonucleotides/chemical synthesis , Base Sequence , DNA/chemistry , DNA/pharmacology , Deoxyribonuclease HindIII/metabolism , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Nucleic Acid Denaturation , Oligodeoxyribonucleotides/chemistry , Oligodeoxyribonucleotides/pharmacology , Temperature
13.
Nucleic Acids Res Suppl ; (1): 59-60, 2001.
Article in English | MEDLINE | ID: mdl-12836263

ABSTRACT

Treatment of 1-[(1'R,2'S,3'S,4'S)-4'-methanesulfonyl-2',3'-O- isopropylidenedioxycyclopentan-1'-yl]-1-H-uracil with LiN3 gave 1-[(1'R,2'S,3'R)-2',3'-O-isopropylidenedioxy-4'- cyclopenten-1'-yl]-1-H-uracil. When KOBut was added instead of LiN3, 1-[(1'R,2'S)-2',3'-O- isopropylidenedioxy-3'-cyclopenten-1'-yl]-1-H-uracil was produced. An analogous treatment of the methanesulfonyl derivative of thymine was also carried out.


Subject(s)
Antiviral Agents/chemical synthesis , Pyrimidine Nucleosides/chemical synthesis , Acids, Carbocyclic/chemistry , Antiviral Agents/chemistry , Pyrimidine Nucleosides/chemistry
15.
J Comput Assist Tomogr ; 24(5): 788-94, 2000.
Article in English | MEDLINE | ID: mdl-11045704

ABSTRACT

PURPOSE: To determine whether spleen size is related to the severity of esophageal varices or associated gastric varices and liver functions in patients with cirrhosis. METHOD: The authors retrospectively studied spleen size on CT (splenic index [SI] = length x width x height of the spleen), liver functions, and the results of esophagogastric endoscopy in 110 patients with cirrhosis. They also analyzed SI in 112 controls. RESULTS: In controls, body weight, height, and age affected the SI. The SI in patients with uncompensated cirrhosis was greater compared with the SI in those with well-compensated disease (p = 0.0363). The SI in patients with esophageal varices was greater than in patients without esophageal varices (p<0.0001), but patients with and without gastric varices had similar SI values. The SI in patients with the red color signs (red wale marking, cherry red spot, and hematocystic spot) on esophageal varices or with risky varices (enlarged tortuous varices with beady, nodular, or tumor shape associated with red color signs) was greater than in patients without these signs (p = 0.0029 and p = 0.0030, respectively). CONCLUSION: The SI is a good indicator of the severity of esophageal varices and hepatic functional reserve in patients with cirrhosis.


Subject(s)
Esophageal and Gastric Varices/diagnosis , Liver Cirrhosis/complications , Spleen/pathology , Age Factors , Body Constitution , Case-Control Studies , Endoscopy, Digestive System , Esophageal and Gastric Varices/pathology , Female , Humans , Liver Function Tests , Male , Middle Aged , Retrospective Studies , Risk Assessment , Severity of Illness Index , Tomography, X-Ray Computed
16.
Bioorg Med Chem Lett ; 10(4): 329-31, 2000 Feb 21.
Article in English | MEDLINE | ID: mdl-10714492

ABSTRACT

2-Methyladenosine-substituted analogues of 2-5A, p5'A2'p5'A2'p5'(me2A), p5'(me2A)2'p5'A2'p5'A, and p5'(me2A) 2'p5'(me2A)2'pS'(me2A), were prepared via a modification of a lead ion-catalyzed ligation reaction. These 5'-monophosphates were subsequently converted into the corresponding 5'-triphosphates. Both binding and activation of human recombinant RNase L by various 2-methyladenosine-substituted 2-5A analogues were examined. Among the 2-5A analogues, p5'A2'p5'A2'p5'(me2A) showed the strongest binding affinity and was as effective as 2-5A itself as an activator of RNase L. The CD spectra of both p5'(me2A)2'p5'A2'p5'A and p5'A2'p5'A2'p5'(me2A) were superimposable on that of p5'A2'p5'A2'p5'A, indicative of an anti orientation about the base-glycoside bonds as in naturally occurring 2-5A.


Subject(s)
Adenosine Monophosphate/chemistry , Adenosine Monophosphate/pharmacology , Adenosine/analogs & derivatives , Endoribonucleases/drug effects , Oligoribonucleotides/chemistry , Oligoribonucleotides/pharmacology , Adenosine/chemistry , Adenosine/pharmacology , Adenosine Monophosphate/analogs & derivatives , Binding Sites , Catalysis/drug effects , Circular Dichroism , Endoribonucleases/metabolism , Humans , Magnetic Resonance Spectroscopy , Nucleic Acid Conformation , Protein Binding , Recombinant Proteins/drug effects , Recombinant Proteins/metabolism , Structure-Activity Relationship
17.
Nucleic Acids Symp Ser ; (44): 29-30, 2000.
Article in English | MEDLINE | ID: mdl-12903252

ABSTRACT

The unique 2',5'-oligoadenylate (2-5A) acts as a potent inhibitor of translation in vertebrate cells through the activation of a constituent latent 2-5A-dependent endoribonuclease (RNase L). This 2-5A system plays a major role in the interferon natural defense mechanism against viral infection. We report the syntheses of base-modified adenosine-substituted 2-5A derivatives, their interaction with recombinant human RNase L and their biological stability.


Subject(s)
Adenine Nucleotides/chemistry , Adenine Nucleotides/metabolism , Adenosine/analogs & derivatives , Endoribonucleases/metabolism , Oligoribonucleotides/chemistry , Oligoribonucleotides/metabolism , Adenine Nucleotides/chemical synthesis , Adenosine/chemical synthesis , Adenosine/chemistry , Adenosine/metabolism , Humans , In Vitro Techniques , Kinetics , Molecular Structure , Oligoribonucleotides/chemical synthesis , Recombinant Proteins/metabolism , Substrate Specificity
18.
Nucleic Acids Symp Ser ; (44): 111-2, 2000.
Article in English | MEDLINE | ID: mdl-12903293

ABSTRACT

The cellular enzyme S-adenosyl-L-homocysteine (SAH) hydrolase has emerged as a target enzyme for the molecular design of anti-viral agents. Recently, SAH hydrolase has been considered as an attractive target in parasite chemotherapy for malaria. We report synthesis of several carbocyclic purine nucleosides and their inhibitory activities against human and malaria recombinant SAH hydrolases.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Hydrolases/antagonists & inhibitors , Purine Nucleosides/chemical synthesis , Purine Nucleosides/pharmacology , Adenosylhomocysteinase , Animals , Antimalarials/chemical synthesis , Antimalarials/chemistry , Antimalarials/pharmacology , Enzyme Inhibitors/chemistry , Humans , In Vitro Techniques , Molecular Structure , Plasmodium falciparum/enzymology , Purine Nucleosides/chemistry , Recombinant Proteins/antagonists & inhibitors
19.
Nucleic Acids Symp Ser ; (44): 193-4, 2000.
Article in English | MEDLINE | ID: mdl-12903334

ABSTRACT

We investigated the molecular mechanisms of cell death induced by 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106: Figure 1), a potent inhibitor of RNA synthesis, using mouse mammary tumor FM3A cells and human fibrosarcoma HT1080 cells. ECyd induced the characteristics of apoptosis on these cells, such as morphological changes, DNA fragmentations and caspase-3-like protease activation. General caspases inhibitor (Z-Asp-CH2-DCB) inhibited cell death. Interestingly, we also found that ECyd induced rRNA fragmentation with the size of 3.2, 2.8 and 1.5 kb, and which might be caused by inhibition of RNA synthesis. rRNA fragmentation was mainly occurred in D8 domain of 28 S rRNA, and the end of 5'-terminal sequence of 1.5 kb fragment was C3220pC3221p or C3221pG3222p, that was identical to the recognition sequence of RNase L. Furthermore, the fragmentation patterns of rRNA digested with RNase L resembled that of ECyd treated cells in shape. These results indicate that antitumor mechanisms of ECyd are involved in activation of RNase L. rRNA fragmentation may be one of the death events as a result of inhibition of RNA synthesis and play an important role in the antitumor activity of ECyd.


Subject(s)
Cytidine/analogs & derivatives , Cytidine/pharmacology , Nucleic Acid Synthesis Inhibitors/pharmacology , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Endoribonucleases/metabolism , Enzyme Activation/drug effects , Humans , Mice , RNA, Neoplasm/metabolism , RNA, Ribosomal/metabolism , Tumor Cells, Cultured
20.
DNA Res ; 6(5): 307-12, 1999 Oct 29.
Article in English | MEDLINE | ID: mdl-10574457

ABSTRACT

We report the nucleotide sequence of a gene encoding the c ('16 kDa') subunit of the vacuolar-type H+-ATPase (V-ATPase) from a marine red alga, Porphyra yezoensis. A cDNA clone was isolated from a leafy gametophyte cDNA library and analyzed for the sequence. The genomic DNA sequence was directly determined by nested PCR. The structural gene contained four introns within a coding sequence of 483 base pairs which encodes a polypeptide of 161-amino acids with four hydrophobic transmembrane-spanning regions. Comparison of the deduced amino acid sequences showed higher similarity to the land plant Oryza sativa (69.1%) than to the Ulvophyceae Acetabularia acetabulum (64.1%). The mRNA was detected both in the leafy gametophytes and filamentous sporophytes.


Subject(s)
Proton-Translocating ATPases/genetics , Rhodophyta/genetics , Vacuolar Proton-Translocating ATPases , Amino Acid Sequence , Base Sequence , Blotting, Northern , DNA, Complementary/genetics , Genes , Molecular Sequence Data , Proton-Translocating ATPases/chemistry , Proton-Translocating ATPases/metabolism , Rhodophyta/enzymology , Sequence Alignment , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...